HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
Huagongshe Open Program:[email protected]AI access: llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.7.9
  1. Home
  2. /Compound

9-Methyl-3-oxa-9-azatricyclo(3.3.1.02,4)nonan-7-yl tropate

HCID 5184
New noteNew reactionRequest quotesPrint preview
Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
475199-31-6
Standard SMILES
CN1C2CC(OC(=O)C(CO)c3ccccc3)CC1C1OC12
InChIKey
STECJAGHUSJQJN-UHFFFAOYSA-N
Molecular formula
C17H21NO4
Average molar mass
303.35 g/mol
Monoisotopic mass
303.14705815

Overview

LSM-1330 is a 3-hydroxy carboxylic acid.

Names & identifiers

Preferred name
9-Methyl-3-oxa-9-azatricyclo(3.3.1.02,4)nonan-7-yl tropate
IUPAC
(9-methyl-3-oxa-9-azatricyclo[3.3.1.02,4]nonan-7-yl) 3-hydroxy-2-phenylpropanoate

Names & synonyms

DTXSID60858963475199-31-69-Methyl-3-oxa-9-azatricyclo(3.3.1.02,4)nonan-7-yl tropate9-Methyl-3-oxa-9-azatricyclo[3.3.1.02,4]nonan-7-yl tropateRefChem:1075018DTXCID90196688scopolamine(-)-Scopolamine51-34-3AtroscineSkopolaminCHEMBL13030
Show more names
Scopoderm-TTS138-12-5Plexonal9-methyl-3-oxa-9-azatricyclo[3.3.1.0~2,4~]non-7-yl tropateAtroscinScopolamine?NSC61806SCHEMBL16227

Database identifiers

CAS
475199-31-6
PubChem CID
5184
DTXSID
DTXSID60858963
ChEMBL
CHEMBL13030
ChEBI
CHEBI:91541
Nikkaji
J1.587.795B

Properties

Computed structural properties

XLogP
0.9
Topological polar surface area
62.3 Ų
Hydrogen bond donors
1
Hydrogen bond acceptors
5
Rotatable bonds
5
Heavy atoms
22
Formal charge
0
Complexity
418

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

Toxicology

Exposure RoutesParental (intravenous, intramuscular, and transdermal); oral
Toxicity SummaryScopolamine acts by interfering with the transmission of nerve impulses by acetylcholine in the parasympathetic nervous system (specifically the vomiting center).
Carcinogen ClassificationNo indication of carcinogenicity to humans (not listed by IARC).

Chemistry & industry

Pharmacology

Metabolism/MetabolitesRoute of Elimination: Less than 10% of the total dose is excreted in the urine as parent and metabolites over 108 hours. Half Life: 4.5 hours

Uses & manufacturing

UsesFor the treatment of excessive salivation, colicky abdominal pain, bradycardia, sialorrhoea, diverticulitis, irritable bowel syndrome and motion sickness.

Suppliers

Loading…

Open inquiries

Loading…

Related reactions

1 records
New reaction record
HRID 933585 reaction equation
HRID 933585As reactantValidation data from https://doi.org/10.1039/C8SC04228D

Compound notes

Loading…

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes